Advances in Human Biology

: 2019  |  Volume : 9  |  Issue : 2  |  Page : 116--123

Pharmacological evaluation of Hibiscus abelmoschus against scopolamine-induced amnesia and cognitive impairment in mice

Astha Nigam, Mayank Kulshreshtha, Dharamveer Panjwani 
 Department of Pharmacology, School of Pharmacy, Babu Banarasi Das University, Lucknow, Uttar Pradesh, India

Correspondence Address:
Dharamveer Panjwani
Department of Pharmacology, School of Pharmacy, Babu Banarasi Das University, Lucknow, Uttar Pradesh


Objective: Progressive loss of memory has a prominent role in devastating neurodegenerative diseases such as amnesia, dementia and Alzheimer's disease. The present study was, thus, designed to investigate the potential of Hibiscus abelmoschus (H. abelmoschus) in scopolamine-induced amnesic Swiss Albino mice. Materials and Methods: Phytochemical and acute toxicity studies of H. abelmoschus ethanolic extract (HAEE) were performed. Memory loss was induced by scopolamine (1 mg/kg, i.p), a muscarinic antagonist, and evaluated by using Morris water maze (MWM), elevated plus maze (EPM) and modified passive avoidance tests on Swiss Albino mice. Besides this, locomotor activity, serum biochemical parameters such as total cholesterol and triglyceride levels were evaluated. Lipid peroxidation (LPO), glutathione (GSH) level and catalase (CAT) activity were also checked. HAEE at a dose of 200 and 400 mg/kg body weight administered orally to the animals. Donepezil hydrochloride (1 mg/kg) was taken as standard. Results: Pre-treatment of mice with HAEE significantly reversed scopolamine-induced memory impairments, as evidenced by a significant decrease in escape latency in the MWM task, transfer latency in EPM task and an increase in step-down latency in the modified passive avoidance task. HAEE also exhibited a remarkable cholesterol and triglyceride-lowering property in the present study. Moreover, treatment with HAEE (200 and 400 mg/kg, p.o) to scopolamine-induced rats significantly decreased the LPO and increased the GSH and catalase levels. Conclusion: The memory restorative effects of H. abelmoschus in amnesia may involve its multiple functions including antioxidative and lipid-lowering properties and the presence of phytoconstituents. Thus, H. abelmoschus may act as memory enhancer and may also be useful as a supportive adjuvant in the treatment of impaired memory functions.

How to cite this article:
Nigam A, Kulshreshtha M, Panjwani D. Pharmacological evaluation of Hibiscus abelmoschus against scopolamine-induced amnesia and cognitive impairment in mice.Adv Hum Biol 2019;9:116-123

How to cite this URL:
Nigam A, Kulshreshtha M, Panjwani D. Pharmacological evaluation of Hibiscus abelmoschus against scopolamine-induced amnesia and cognitive impairment in mice. Adv Hum Biol [serial online] 2019 [cited 2019 Dec 12 ];9:116-123
Available from:

Full Text


Memory is a vital function of brain, includes basically three main stages, namely, acquisition, consolidation and retrieval. Learning a task is acquisition; process through which the memory stabilises is consolidation and bringing back of the learned task is retrieval.[1] If there is no learning, there can be no memory later.[2] Part of memory which comes to be known through perception, reasoning, intuition and knowledge is cognition which involves a plethora of functions such as attention, perception, memory coding, retention, recall, decision-making along with reasoning, problem-solving, imaging, planning and executing actions.[3] Decline in memory functions is supposed to be related to various etiological factors such as increasing age, production of free radicals, up and downs of emotions, reduction in cholinergic firing in brain, elevated oxidative stress, hypercholesterolaemia and neuroinflammatory reactions, which causes occurrence of amnesia, dementia to more threatening conditions such as schizophrenia and Alzheimer's disease (AD).[4],[5],[6]

The estimated global dementia prevalence in people aged over 60 is approximate 3.9% with regional prevalence being 1.6% in Africa, 3.9% in Eastern Europe, 4.0% in China, 4.6% in Latin America, 5.4% in Western Europe and 6.4% in North America. There will be an exponential increase in age-related neurodegenerative patients, as estimated by United Nations which depicts its range from 25.5 million in 2000 to an approximately 114 million in 2050.[7] Furthermore, in India, the patients of AD and other dementias are raising their counts and are expected to become thrice as now by 2050.

The cholinergic system plays an important role in learning and memory.[8] The neurotransmitter acetylcholine has important recognition functions such as memory,[9] and it is synthesised in certain neurons by the enzyme choline acetyltransferase from choline to acetyl-CoA. Acetylcholinesterase (AChE) is an enzyme that hydrolyses acetylcholine into choline and acetate.[10] A loss of cholinergic neurons and reduced choline acetyltransferase activity in the cerebral cortex and hippocampus is consistent with findings in AD.[11],[12],[13]

Since ages, drugs and natural remedies have been prescribed to enhance memories in people. The Indian System of Medicine Ayurveda has a treasury of such memory enhancing drugs, which are today popular all over the world due to their proven effective qualities. The herbs acting on the brain are called as Nootropic herbs (Nootropic is derived from Greek and means acting on the mind) and their isolated constituents referred to as smart drugs. Memory enhancer herbs enhance the memory and increase blood circulation in the brain.[14]

H. abelmoschus (syn: Abelmoschus moschatus), belonging to Family Malvaceae, is a native of India and grows in the tropical subtropical and hilly regions of country.[15] Seeds of this herb are commonly named 'Musk daana.' Phytochemical studies have identified the presence of a wide variety of constituents such as flavonoids like myrecetin, quercetin, along with glycosides and β-sitosterol. It was mentioned in traditional Indian medicine as a useful therapy for treating nervous debility, hysteria and other nervous disorders and for the treatment of intestinal complaints, constipation, dyspepsia and gonorrhoea. It acts as cardiac tonic, aphrodisiac, diuretic and antispasmodic.[16],[17] Seeds and leaves of H. abelmoschus are found to possess various pharmacological properties, such as larvicidal, antioxidant, antimicrobial, aphrodisiac, skin protective, wound healing, antilithiatic activity and sexual activity for the treatment of impotency.[18],[19],[20],[21],[22],[23]

The present research was thus, carried out to evaluate the effect of ethanolic extract of seed of H. abelmoschus on learning and memory activity at different doses against scopolamine-induced amnesia in mice.

 Materials and Methods

Plant material

Seeds of H. abelmoschus, were purchased from N. N. Aushdhalaya, Lucknow and authenticated by Dr. RR Singh, ex-HOD, Department of Botany, Lucknow University, Lucknow, UP, India, and a voucher specimen was deposited (Ref. no. Bot/Q/2323).

Preparation of the extract

The seeds of H. abelmoschus were cleaned, dried and coarsely powdered. A weighed quantity of the coarse powder was taken and extracted with 70% ethanol in a soxhlet apparatus. The extract was concentrated to dryness with the help of rotary evaporator and finally, air-dried thoroughly to remove all traces of the solvent. The H. abelmoschus ethanolic extract (HAEE) was kept for further analysis. The yield of the HAEE was found to be 11.5%.[24]

Experimental animals

Swiss Albino mice (25–35 g, either sex) were used in this study after Institutional Animal Ethics Committee approval (IAEC No. BBDNIIT/IAEC/022/2014). The mice were allowed free access to food and water ad libitum. Animals were kept in polyacrylic cage in groups of six/cage and maintained under standard housing conditions (temperature: 24°C–27°C and humidity: 60%–65%) with 12 h light and dark cycle. Animals were acclimatized for at least 7 days to the laboratory conditions before behavioural experiments. Experiments were carried out between 900 h and 1600 h to avoid experimental deviations due to diurnal variations.

Drugs and chemicals

Scopolamine hydrobromide (Sigma-Aldrich, USA), 5,5'-dithiobis-(2-nitrobenzoic acid), (Ellman's reagent), trichloroacetic acid and thiobarbituric acid (TBA) were purchased from Sigma-Aldrich (Bangalore, India) Dithiobis-nitrobezoic acid (SD Fine-Chem Limited), Donepezil (as a gift sample from Vasudha Pharma, Hyderabad), all other chemicals and reagents used for the study were of analytical grade.

Grouping and treatment protocol

Learning and memory were assessed with three behavioural models, namely, Morris water maze (MWM), elevated plus maze (EPM) and modified passive avoidance test. Animals were randomly divided into five groups of six animals each. The grouping for pharmacological screening models was as follows:

Group 1: Positive control (PC) mice received only vehicleGroup 2: Negative control (NC) mice received vehicle and scopolamine (1 mg/kg, i.p)Group 3: Standard drug (STD), donepezil (1 mg/kg, i. p.) and scopolamine (1 mg/kg, i.p)Group 4: Lower dose of HAEE (T1) (HAEE 200 mg/kg, p. o) and scopolamineGroup 5: Higher dose of HAEE (T2) (HAEE 400 mg/kg, p. o) and scopolamine.

These animals were dosed once daily with the respective drugs. Donepezil and scopolamine hydrochloride were dissolved in distilled water and administered intraperitonealy, while HAEE was administered orally after get dissolved in distilled water.[25]

Acute toxicity study

Mice were kept on overnight fasting and water was withdrawn 3–4 before administration of test compound. HAEE was administered orally in increasing doses of 50, 100, 500, 1000, 2000 and 4000 mg/kg body weight. Immediately after dosing, the mice were observed continuously for 4 h for symptoms of toxicity such as motor activity, tremors, convulsions, tonic extension, muscle spasm, loss of righting reflex, ataxia, sedation, hypnosis, lacrimation, diarrhoea, salivation and writhing. Mice were then kept under observation up to 72 h for any mortality.

Memory models

Induction of amnesia

Amnesia was induced in mice by using scopolamine at a dose of 1 mg/kg, i.p only once during the model. It was given 30 min before retention trial in MWM, and 30 min before acquisition trial in EPM. In modified passive avoidance, it was injected to animals 30 min before acquisition trial.

Morris water maze

The maze was a white circular pool (100 cm diameter and 50 cm height) with a featureless inner face filled with water (20°C ± 1°C) upto a depth of 30 cm. The treatment was allotted to animals for 14 days. Scopolamine was injected on day 14 1 h after all treatments. The animals were trained for maze task from day 10th to 13th four times per day at a intertrial gap of 5 minutes. Mice failed to find the platform within the allotted period (120 s, initial learning period; 180 s, scopolamine-induced amnesia trials) were placed on the platform for 30 s. On day 14, water made opaque by adding milk and animals were tested three times with each of the three trials being performed between 30 and 45 min following scopolamine injection. Escape latency, number of crossing and residence time were evaluated as parameters for testing of spatial learning.[4],[26]

Elevated plus maze

Elevated plus maze served as the exteroceptive behavioural model to evaluate long-term memory in mice. Grouping and dosing schedule were same as MWM test. Maze consisted of two open (16 × 5) and two closed arms (16 × 5 × 20). All treatments were given for 14 days. On the 14th day, after 60 min of administration of treatments, scopolamine (1 mg/kg, i.p) was injected to all groups except Group 1. After 30 min of scopolamine injection, animals were placed individually at the end of either of the open arm, facing away from the centre and the time taken by the animal to move from open-to-closed arm, i.e., transfer latency (TL) was noted for the acquisition trial. TL was defined as the time (in seconds) taken by the animals to move from the open arm into one of the covered arms with all its four legs.[27] If the mice were unable to reach the closed arm within allotted period, that is, 180 s, it was placed into one of the closed arms for 15 s, so as to explore it and the TL was taken as 180 s.[28] After 24 h of exposure, the procedure was again repeated and TL was recorded as the parameter for memory on the day of retention.

Modified passive avoidance test

Passive avoidance apparatus is based on negative reinforcement was used to examine long-term memory. The apparatus consisted of a rectangular box (27 cm × 27 cm × 27 cm) having three walls of wood and one wall of Plexiglas featuring a grid floor (3-mm stainless steel rods set 8 mm apart), with a wooden platform (10 cm × 7 cm × 1.7 cm) at the centre of the grid floor an electric shock was delivered to the grid floor. The box was illuminated with a 15 W bulb during the experimental period. All treatments were given to the animal for 14 days. On the 14th day, scopolamine was injected to the animals after 60 min of drug administration. After 30 min of scopolamine injection each mice were placed on a wooden platform set in the centre of the grid floor. When the mice stepped down and placed its paw on the grid floor, shock (foot shock: 50 Hz; 1.5 mA; 1 s) was delivered and the step-down latency (SDL) was recorded. SDL is defined as the time taken by the mice to step down and place all four paws on the grid floor. Mice showing SDL in the range of 2–15 s were taken for the acquisition and the retention tasks. The acquisition task was carried out 90 min after the training session. During the acquisition test, animals were removed from the shock-free zone if they did not step down for a period of 60 s. Retention was tested after 24 h in a similar manner, except with an upper cut-off time of 180 s.[29],[30],[31]

Locomotor activity

The locomotor activity was studied using actophotometer, which operates on photoelectric cells are connected in circuit with a counter when the beam of light falling on photocell is cut off by the animal, a count is recorded. The animals were placed individually in the activity cage for 5 min and the activity was monitored. The photocell count was noted and decrease or increase in locomotor activity was calculated.[30],[32]

Biochemical estimation

Biochemical tests were conducted 24 h after the last behavioural test, that is, MWM. Following the completion of experiment on the 14th day, blood was collected from retro-orbital plexus under mild ether anaesthesia. The collected blood was centrifuged to separate serum for estimation of serum cholesterol and triglyceride levels. After collection of blood, the animals were sacrificed by decapitation. Brains were removed and rinsed with ice-cold isotonic saline. Brains were then homogenised with ice cold 0.1 mmol/l phosphate buffer (pH 7.4). The homogenates (10% w/v) were then centrifuged at 10,000 g for 15 min and the supernatant so formed was used for the biochemical estimations.[30]

Measurement of lipid peroxidation

The extent of lipid peroxidation (LPO) in the brain was determined quantitatively by performing the method as described by Ohkawa et al.[32] The amount of malondialdehyde (MDA) was measured by reaction with TBA at 532 nm using spectrophotometer.[33]

Catalase activity

Catalase activity was assessed by the method of Beer and Sizer, based on the ability of catalase to oxidise hydrogen peroxide. The change in absorbance was recorded for 3 min.[34]

Glutathione levels

Glutathione (GSH) level was measured as non-protein thiols based on the protocol developed by Ellman (1959). The homogenate was precipitated in cooled trichloroacetic acid 10% and centrifuged at 15,000 g for 2 min, and the supernatant was incubated with 5,5'-dithiobis-(2-nitrobenzoic acid) or DTNB in a 1 M phosphate buffer, pH 7.0. Absorbances were measured at 412 nm. A standard curve of reduced GSH was used to calculate the GSH levels.[35]

Statistical analysis

Statistical analysis was performed by one-way analysis of variance (ANOVA) with Tukey's post-hoc test. Values are expressed as mean ± standard error of the mean (SEM).

 Results and Discussions

Preliminary phytochemical analysis

The preliminary phytochemical studies were performed for testing different phytochemical constituents present in HAEE. The observations showed the presence of alkaloids, flavonoids, glycosides, tannins and the absence of saponins [Table 1].{Table 1}

Acute toxicity studies

In acute toxicity study, HAEE did not show any mortality in mice. Even at this higher dose, i.e., 4000 mg/kg, there were no gross behavioural changes such as skin, fur condition, eyes colour, motor activity, convulsions, tonic extension, loss of righting reflex, ataxia, sedation, hypnosis and writhing were observed, and 200 and 400 mg/kg doses were used for the evaluation of different activities.

Morris water maze

The effect of HAEE (200 and 400 mg/kg, p.o) on spatial long-term memory was evaluated using the MWM task. Daily administration of both the doses of HAEE and STD for 14 days significantly decreased latency to find hidden platform when compared to NC group, indicating their effect on improvement in learning and memory in retention trial. Scopolamine increased the latency to find hidden platform, but at the end of the experiment, escape latency was decreased in HAEE-treated groups at the dose of 400 mg/kg. Donepezil showed maximum reduction in escape latency. However, there were no significant differences in number of crossings and residence time between negative control (NC) and HAEE-treated groups during training and hidden platform trial [Table 2] and [Table 3].{Table 2}{Table 3}

Elevated plus maze

The effect of the vehicle, scopolamine control, HAEE (200 and 400 mg/kg) and donepezil (1 mg/kg) were evaluated at the end of day 14. The scopolamine control group showed a significant increase in TL values on the acquisition as well as on the retention days as compared with vehicle control rats, indicating impairment in learning and memory. In the retention trial on day 15, the result analysis revealed significant differences in TL in EPM performance between HAEE (200 and 400 mg/kg) and NC group animals (***P < 0.001). The results were comparable with donepezil (1 mg/kg). TL of 2nd day (day 15) reflected retention of learned task or memory [Table 4].{Table 4}

Modified passive avoidance

In the modified passive avoidance test, scopolamine decreased SDL on the acquisition and retention trial training, indicating impairment of memory. SDL of the 2nd day (day 15 of drug treatment) reflected the long-term memory of animals. There was a statistically significant increase (***P < 0.001) in SDL after the administration of HAEE (200 and 400 mg/kg po) for 14 days as compared with the NC group in learning and memory of mice. However, donepezil showed maximum increase in SDL [Table 5].{Table 5}

Locomotor activity

The HHAE at doses of 200 and 400 mg/kg p.o did not produce any significant reduction in locomotor activity as compared to the control animals receiving only the vehicle. Furthermore, the scopolamine control group and the donepezil-treated group failed to produce any significant effect on locomotor activity as compared to the control. This result indicates that the scopolamine injection did not affect the general locomotor activities of the mice, but gave rise to learning disabilities in them [Table 6].{Table 6}

Effect of Hibiscus abelmoschus ethanolic extract on biochemical parameters

HAEE at the doses of 200 and 400 mg/kg showed marked reduction in serum total cholesterol and a significant reduction in triglyceride levels. The dose of 200 mg/kg showed more reduction in cholesterol level as compared to test group 2 of 400 mg/kg. Donepezil showed reduction in blood cholesterol level of mice similar to HAEE (200 mg/kg) [Table 7].{Table 7}

Effects of Hibiscus abelmoschus ethanolic extract on malondialdehyde levels and antioxidant enzyme activities

The analysis of MDA levels using one-way ANOVA showed a difference among the five groups. Between-groups comparisons indicated stress exposure significantly increased MDA levels in NC group compared to PC group. HAEE treatment caused a significant decrease in the MDA levels when compared to the NC group. Furthermore, there was a significant decrease in MDA levels of standard group as compared to NC group. Furthermore, one-way ANOVA on catalase and GSH levels revealed a significant difference in five groups. Between-groups comparisons indicated stress exposure significantly decreased catalase and GSH levels in NC group compared to PC group. HAEE treatment at a dose of 400 mg/kg caused a significant increase in the catalase and GSH levels when compared to the NC group. Furthermore, there was a significant increase in catalase and GSH levels of the standard group as compared to NC group.

Oxidative parameters

In the restraint stress-induced model, catalase, GSH and LPO decreased and increased, respectively, in stressed group compared with the unstressed group. HAEE increased catalase, GSH level and decreased LPO as compared to NC group. Similarly, donepezil treatment also increased catalase, GSH level and depleted LPO compared with stressed group [Table 8].{Table 8}


Herbal extracts with multiple active constituents have emerged as preferred prophylactics owing to their broad spectrum curative potential and minimum negative effects when compared to synthetic molecules. H. abelmoschus seeds have been recommended in traditional Indian Medicine System for the treatment of nervous debility, disorders and hysteria, but no research has been done yet. The present study, thus, demonstrates beneficial effect of HAEE on scopolamine-induced amnesia as assessed by behavioural test using MWM, EPM, modified passive avoidance test and biochemical parameters such as total serum cholesterol and triglyceride levels.

Scopolamine interferes with memory and cognitive function in human beings and experimental animals by blocking muscarinic receptors[36] along with the impairment of long-term potentiation and the central cholinergic system.[4] Its interference in acetylcholine transmission in the central nervous system proved it as a useful experimental animal model to screen for drugs with potential therapeutic value in dementia. It is reported that memory impairment in the scopolamine (1 mg/kg, i.p)-induced animal model is associated with the increased oxidative stress within rat and mice brain. We treated mice with scopolamine and corroborated that it increased EL in MWM, TL in EPM and reduced SDL in passive avoidance, which would validate our paradigm as an effective measurement of learning and memory in mice.[37]

Donepezil is a reversible and highly selective acetylcholinesterase inhibitor with a long plasma half-life of approximately 70 h that is approved for the enhancement of memory function in AD. The results of MWM and EPM task had shown significant effectiveness in observed parameters when compared with NC group. The main mechanism of action through which it influences cognition and function is presumed to be the inhibition of AChE enzyme in the brain along with the prevention of free radical-mediated neuroinflammation, upregulation of ChAT, which is known to be responsible for the synthesis of ACh or enhancement of release of ACh through nicotinic receptors.[38],[39],[40],[41],[42]

The MWM learning task is used to assess hippocampal-dependent spatial learning ability.[4] In the present study, the results obtained from a MWM test in all groups during the training phase showed normal learning profiles as indicated by decreases of escape latencies from day 1 to 4. A decrease in day 4, escape latencies (ELT) of control animals during on-going acquisition trials denoted normal acquisition of memory and an increase in time spent in target quadrant, in search of the missing platform during retrieval trial indicated, retrieval of memory[43] which was shown by HAEE treatment. The accurate directionality of their escape behaviour (and other measures of performance) provides evidence that rats escape by learning the spatial position of the platform relative to distal cues.[24]

The EPM paradigm (TL) was employed to deduce spatial long-term memory of animals.[44] Decrease in TL on the 2nd day (i.e., 24 h after the first trial) indicated improvement of memory.[45] It showed retention or consolidation of memory, whereas acquisition of memory-related action of drugs was checked by treating the animals before 1st day. There was also improvement in cognition of animals as indicated by quick migration of mice after exposure to open arm.[46]

The step-down type of passive avoidance task has been used to examine the long-term memory based on negative reinforcement.[44] In case of the passive avoidance paradigm, the SDL was increased on the administration of HAEE[47] which was also recorded before to determine memory disturbance produced by the cholinergic antagonist scopolamine.[45] With 200 mg/kg dose, the increase in number of avoidances and prolongation of SDL (mice remained on the platform for longer time) was higher than 400 mg/kg, but not significantly different than standard.

Epidemiological studies have found positive correlations between hypercholesterolemia and development of AD.[48] In our study, H. abelmoschus decreased the serum cholesterol level as compared to NC. Cholesterol turnover appears to play a crucial role in the deposition and clearance of amyloid peptide in the brain, and in high risk of developing AD,[49] and drugs, that inhibit cholesterol synthesis lower amyloid-beta (Aβ) in these cases.[26] HAEE at both the doses significantly lower the serum cholesterol and triglyceride level which showed its hypolipidaemic nature.

There is a growing body of evidence in the literature that indicates oxidative stress as a crucial factor for several disorders including dementia, furthermore, data indicate that oxidative stress is one of the earliest events in pathogenesis of memory impairment.[50] Oxidative stress is thought to be important in the progression of AD and is temporally linked to the development of plaques and neurofibrillary tangles.[51] The LPO is well-known elements to play an essential role in oxidative stress balance.[50] It is demonstrated increased oxidation of lipids, proteins and deoxyribonucleic acid, alterations in mitochondrial function and a possible role of Aβ and its precursor protein in oxidative reactions in experimental models of AD. Scopolamine-induced TBA reactive substance activity represents an important marker for LPO in the frontal cortex and hippocampus. Because oxidative stress contributes significantly to the perturbation of calcium homeostasis and subsequent apoptosis, as seen in AD patients.[4] There is considerable evidence that scopolamine leads to oxidative stress in rat leading to cognitive impairment.[50]

LPO may enhance due to depletion of GSH content in the brain, which is often considered as the first-line of defence of the cell by this endogenous antioxidant against oxidative stress. Evidence has been presented that the neuronal defence against H2O2, which is the most toxic molecule to the brain, is mediated primarily by the GSH system. GSH is a tripeptide, an endogenous antioxidant found in all animal cells in variable amounts and is a very accurate indicator of oxidative stress. MDA is an indicator of LPO.[25] In the present study, scopolamine administration increased (1.21 ± 0.17), the MDA level when compared to PC (0.50 ± 0.07) mice. Donepezil appreciably decreased (P < 0.001) (0.03 ± 0.04) the MDA level when compared to scopolamine-administered mice. HAEE (200 mg/kg, p.o) administration did not produce any considerable changes (P > 0.05) in MDA level when compared to scopolamine-administered mice. HAEE administered mice at the dose of 400 mg/kg, p. o appreciably decreased (0.70 ± 0.03) in MDA level when compared to NC group.[25]

Catalase is the major enzymatic defence for aerobic cells combating the toxic effect of superoxide radicles.[51] Catalase has the capability to detoxify H2O2 radicals. Release of H2O2 promotes the formation of numerous other oxidant species that greatly contributes for oxidative stress leading to the pathogenesis of AD. The present study shows that scopolamine treatment decreased brain catalase activity and pre-treatment with EEAS (400 mg/kg, p.o) remarkably restored catalase activities. Improvement of catalase activity was observed in standard and HAEE-treated groups compared to NC.[29]

GSH is a premiere cellular antioxidant. It exists in reduced (GSH) and oxidized (glutathione disulfide [GSSG]) states within our cells. In the reduced state, the thiol group of cysteine are able to quench free radicals by donating a reducing equivalent (H++ e-). This includes quenching various reactive oxygen species that are generated during the use of oxygen by our cells in aerobic metabolism. In donating an electron, GSH itself becomes reactive but readily reacts with another reactive GSH to form GSSG. This is possible due to the normally high concentration of GSH in cells (up to 5 mM in the liver). GSH can be regenerated from GSSG by the enzyme GSH reductase.[52]

The phytochemical studies showed the presence of high amounts of flavonoids[53] and polyphenols which are known to possess antioxidative, free radical scavenging and LPO inhibition activity.[17] Flavonol myricetin (3,5,7,3′,4′,5′-hexahydroxy flavone), the active principle of A. moschatus, has proven activity of antioxidative and cytoprotective.[54] One more flavonoid, i.e., quercetin which is also identified in plant through studies[25] has been demonstrated to improve cerebral blood flow along with preventing memory impairment, oxidative stress, altered brain energy metabolism and cholinergic dysfunction in mice.[55] HAEE exhibited significant activity against scopolamine-induced amnesia, probably due to the presence of high amount of flavonoids and polyphenols. These antioxidant, free radical scavenging and LPO inhibitory activity are probably the basic mechanism of plant for anti-amnesic activity. LPO inhibitory activity of A. moschatus extracts may be the probable mechanism of hypolipidaemic activity.[56]


Our results suggested that HAEE pre-treatment prevents scopolamine-induced impairment of memory in MWM, EPM and modified passive avoidance test. Plant was also effective in improving the lipid profile of animal, although the cellular and molecular mechanisms that underlie the action of HAEE were not fully understood. Thus, it can be concluded that plant has the potential to be considered as a therapeutic agent and it would be beneficial to explore it.


The authors would like to express their hearty thanks to Dr. Sunita Garg, NISCAIR, New Delhi for the authentication of plant material.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


1Farahmandfar M, Naghdi N, Karimian SM, Kadivar M, Zarrindast MR. Amnesia induced by morphine in spatial memory retrieval inhibited in morphine-sensitized rats. Eur J Pharmacol 2012;683:132-9.
2Johansen JP, Cain CK, Ostroff LE, LeDoux JE. Molecular mechanisms of fear learning and memory. Cell 2011;147:509-24.
3Pawlik P, d'Ydewalle G, editors. Psychological Concepts: An International Historical Perspective. Hove, UK: Psychology Press; 2006.
4Alikatte KL, Akondi BR, Yerragunta VG, Veerareddy PR, Palle S. Antiamnesic activity of Syzygium cumini against scopolamine induced spatial memory impairments in rats. Brain Dev 2012;34:844-51.
5Habbu PV, Mahadevan KM, Shastry RA, Chilakwad SR. Antiamnesic potentiality of Argyreia speciosa (Burm.f) Boj. in mice. Int J Green Pharm 2010;4:83-9.
6Yadav KD, Reddy KR, Kumar V. Encouraging effect of Brahmi Ghrita in amnesia. Int J Green Pharm 2013;7:122-6.
7Eckert GP. Traditional used plants against cognitive decline and Alzheimer disease. Front Pharmacol 2010;1:138.
8Blokland A. Acetylcholine: A neurotransmitter for learning and memory? Brain Res Brain Res Rev 1995;21:285-300.
9Johnston MV, Alemi L, Harum KH. Learning, memory and transcription factors. Int Pediatr Res Found 2003;53:369-74.
10Kiran R, Rao GS, Krishna NS, Jahnavi NB, Begum SA, Anusha E. Memory enhancing activity of Ageratum conyzoides L. on corticosterone induced dementia in mice. Int J Pharmacol Screen Meth 2012;2:77-81.
11Cummings JL, Kaufer D. Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited. Neurology 1996;47:876-83.
12Gupta J, Kulshreshtha M. Memory impairment with reference to Alzheimer's disease: An update. Int J Nutr Pharmacol Neurol Dis 2017;7:45-53.
13Kwon SH, Kim HC, Lee SY, Jang CG. Loganin improves learning and memory impairments induced by scopolamine in mice. Eur J Pharmacol 2009;619:44-9.
14Rathee P, Chaudhary H, Rathee S, Rathee D. Natural memory boosters. Phcog Rev 2008;2:249-56.
15Joy PP, Thomas J, Mathew S, Skaria BP. Medicinal plants. In: Bose TK, Kabir J, Das P, Joy PP, editors. Tropical Horticulture. Vol. 2. Calcutta: Naya Prokash; 2001. p. 449-632.
16Nandkarni MK. Indian Materia Medica. Mmbai: Popular Prakashan Pvt Ltd; 1996.
17Gul MZ, Bhakshu LM, Ahmad F, Kondapi AK, Qureshi IA, Ghazi IA, et al. Evaluation of Abelmoschus moschatus extracts for antioxidant, free radical scavenging, antimicrobial and antiproliferative activities using in vitro assays. BMC Complement Altern Med 2011;11:64.
18Dua VK, Pandey AC, Alam ME, Dash AP. Larvicidal activity of Hibiscus abelmoschus linn. (Malvaceae) against mosquitoes. J Am Mosq Control Assoc 2006;22:155-7.
19Warghat AR, Nandkishor RH, Wagh P.In vitro callus induction of Abelmoschus moschatusmedik. L. by using different hormone concentration. Int J Pharm Sci Rev Res 2011;10:82-4.
20Rival D, Bonnet S, Sohm B, Perrier E. A Hibiscus abelmoschus seed extract as a protective active ingredient to favour FGF-2 activity in skin. Int J Cosmet Sci 2009;31:419-26.
21Rahman MA, Uddin SB, Wilcock CC. Medicinal plants used by chakma tribe in hill tracts districts of Bangladesh. Indian J Tradit Know 2007;6:508-17.
22Christina AJ, Muthumani P. Phytochemical investigation and antilithiatic activity of Abelmoschus moschatus medikus. Int J Pharm Pharm Sci 2013;5:108-13.
23Ahmed KA, Venkataraman BV. Assessment of a polyherbal ayurvedic medicine for sexual activity in rats. Indian Drugs 1999;36:576-82.
24Kulshreshtha M, Dwivedi H, Singh MP. Antimicrobial effects of leaves of Indian herbal plants with reference to peptic ulcer. Environ Dis 2018;3:18-26.
25Jyoti G, Mayank K. Pharmacological investigation and unraveling mechanism of action of Jasminum sambac flowers for predicated treatment of Alzheimer's disease. Curr Nutr Food Sci 2017;13:1-8.
26Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47-60.
27Bhadania M, Joshi H, Patel P, Kulkarni VH. Protective effect of menthol on β-amyloid peptide induced cognitive deficits in mice. Eur J Pharmacol 2012;681:50-4.
28Kulkarni KS, Kasture SB, Mengi SA. Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats. Indian J Pharmacol 2010;42:168-73.
29Sau S, Handral M. Evaluation of memory enhancing activity of leaf extract of Dalbergia sissoo in mice. Int J Pharm Sci Drug Res 2015;7:263-9.
30Skirzewski M, Hernandez L, Schechter LE, Rada P. Acute lecozotan administration increases learning and memory in rats without affecting anxiety or behavioral depression. Pharmacol Biochem Behav 2010;95:325-30.
31Akina S, Thati M, Puchchakayala G. Neuroprotective effect of ceftriaxone and selegiline on scopolamine induced cognitive impairment in mice. Adv Biol Res 2013;7:266-75.
32Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
33Beers RF Jr., Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952;195:133-40.
34Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
35Bihaqi SW, Singh AP, Tiwari M.In vivo investigation of the neuroprotective property of convolvulus pluricaulis in scopolamine-induced cognitive impairments in wistar rats. Indian J Pharmacol 2011;43:520-5.
36Golechha M, Bhatia J, Arya DS. Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice. J Environ Biol 2012;33:95-100.
37Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, et al. Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response. BMC Geriatr 2013;13:56.
38Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL, et al. Chronic treatment of old rats with donepezil or galantamine: Effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 2000;99:17-23.
39Seltzer B. Donepezil: An update. Expert Opin Pharmacother 2007;8:1011-23.
40Umukoro S, Adewole FA, Eduviere AT, Aderibigbe AO, Onwuchekwa C. Free radical scavenging effect of donepezil as the possible contribution to its memory enhancing activity in mice. Drug Res (Stuttg) 2014;64:236-9.
41Su D, Zhao Y, Wang B, Xu H, Li W, Chen J, et al. Isoflurane-induced spatial memory impairment in mice is prevented by the acetylcholinesterase inhibitor donepezil. PLoS One 2011;6:e27632.
42Rinwa P, Jaggi AS, Singh N. Pharmacological investigation of memory restorative effect of Riluzole in mice. Indian J Pharmacol 2012;44:366-71.
43Kulkarni SK. Hand Book of Experimental Pharmacology. Delhi: Vallabh Prakashan; 1999.
44Dhingra D, Kumar V. Memory-enhancing activity of palmatine in mice using elevated plus maze and morris water maze. Adv Pharmacol Sci 2012;2012:357368.
45Yildiz Akar F, Ulak G, Tanyeri P, Erden F, Utkan T, Gacar N, et al. 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats. Pharmacol Biochem Behav 2007;87:434-43.
46Ogasawara T, Itoh Y, Tamura M, Mushiroi T, Ukai Y, Kise M, et al. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer. Pharmacol Biochem Behav 1999;64:41-52.
47Lakshmi V, Adiga S, Bhat P, Chaturvedi A, Bairy KL, Kamath S, et al. Evaluation of the effect of Ferula asafoetida linn. gum extract on learning and memory in wistar rats. Indian J Pharmacol 2012;44:82-7.
48Dalla Y, Singh N, Jaggi AS, Singh D. Memory restorative role of statins in experimental dementia: An evidence of their cholesterol dependent and independent actions. Pharmacol Rep 2010;62:784-96.
49Alhaider IA. Effects of edaravone on scopolamine induced dementia in experiment rats. Int J Pharm 2013;9:271-6.
50Dobhal T, Sharma R, Harikumar SL, Grewal AK. Evaluation of the effect of an ACE-inhibitor in scopolamine-induced memory impairement in mice. Int J Univ Pharm Life Sci 2014;3:231-52.
51Kaur R, Mehan S, Khanna D, Kalra S. Ameliorative treatment with ellagic acid in scopolamine induced Alzheimer's type memory and cognitive dysfunctions in rats. Austin J Clin Neurol 2015;2:1-11.
52Yadav P, Chaudhary G, Singh SL. Investigation on protective effect of Cressa cretica extract in scopolamine induced memory impairment. IJPT 2014;2:13-6.
53Maheshwari P, Kumar A. Antimicrobial activity of Abelmoschus moschatus leaf extracts. Curr Trends Biotechnol Pharm 2009;3:260-266.
54Liu IM, Liou SS, Lan TW, Hsu FL, Cheng JT. Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med 2005;71:617-21.
55Puckhaber LS, Stipanovic RD, Bost GA. Analyses for flavonoid aglycones in fresh and preserved Hibiscus flowers. Herbs, Medicinals and Aromatics. Alexandria: ASHS Press; 2002.
56Tota S, Awasthi H, Kamat PK, Nath C, Hanif K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 2010;209:73-9.